The Permian Basin Development Makes New Mexico a Critical Player in U.S. Oil Production

 

Amidst an ongoing boom in crude oil production in the Permian Basin, an unanticipated focal point has arisen: New Mexico. Over the last two years, the state has contributed to an astonishing 50% of the total increase in oil production from this prolific oil and gas region. The stakes are high, and the unique dynamics of New Mexico’s oil and gas industry are attracting global attention. Will the state maintain its production levels while addressing environmental and infrastructural challenges?

What factors have enabled New Mexico’s rise as a significant oil and gas production player? How is the state navigating regulatory hurdles, environmental concerns, and infrastructural challenges? In a region often overlooked, how has New Mexico managed to defy the odds and achieve such monumental growth in the oil and gas sector?

Gasonomics, hosted by Tim Snyder, Chief Economist at Matador Economics, dives into these questions as he welcomes Willis Scharmer, Energy Expert at ExecHQ, to unpack the intricacies of New Mexico’s oil and gas industry. The discussion elucidates the current state of the industry, its potential challenges, and future prospects.

Key points discussed during the episode include:

  • Understanding the geographical and geological factors that have contributed to the rise in crude oil production in New Mexico
  • An in-depth discussion about the regulatory landscape in New Mexico and how the industry has managed to thrive despite it
  • An overview of the ongoing initiatives to manage environmental impact, including efforts in methane capture and emission reductions

Willis Scharmer brings a wealth of experience in the energy sector. Currently serving as a principal at ExecHQ and heading the energy sector with this consulting consortium, Willis has spent over three decades honing his skills in management, technical matters, and business advising at the corporate level and entrepreneurial development. His professional journey spans various industries, including automotive, energy, healthcare, consulting, and artificial intelligence. Willis holds a mechanical engineering undergraduate degree and an engineering management postgraduate degree from the University of Colorado, Boulder.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More